Thursday, January 24, 2008

Updated NORML Report Highlights The Role Of Pot In Moderating Disease Progression -- ‘Emerging Clinical Applications’ Booklet Reviews Nearly 200 Studi

The Role Of Pot In Moderating Disease Progression

Washington, DC: Clinical and preclinical research on the therapeutic use of cannabis indicates that cannabinoids may curb the progression of various life-threatening diseases – including multiple sclerosis (MS), Alzheimer’s disease, and brain cancer, according to an updated report published today by the NORML Foundation.

The revised report reviews nearly 200 scientific trials assessing the therapeutic utility of cannabinoids for the treatment of seventeen specific disease indications: Alzheimer's disease, Amyotrophic Lateral Sclerosis (ALS), diabetes mellitus, dystonia, fibromyalgia, gastrointestinal disorders, gliomas, hepatitis C, human immunodeficiency virus (HIV), hypertension, incontinence, multiple sclerosis, osteoporosis, pruritis, rheumatoid arthritis, sleep apnea, and Tourette's syndrome.

Hypertension - NORML

Hypertension - NORML

Emerging research indicates that the endogenous cannabinoid system plays a role in regulating blood pressure, though its mechanism of action is not well understood.[1] Animal studies demonstrate that anandamide and other endocannabinoids profoundly suppress cardiac contractility in hypertension and can normalize blood pressure,[2-3] leading some experts to speculate that the manipulation of the endocannabinoid system “may offer novel therapeutic approaches in a variety of cardiovascular disorders.”[4]

free energy gravity pump contest

contest on free energy gravity pump. 10,000 prize

Immediate Heparin Recall by Baxter Healthcare - Orlando Personal Injury Lawyer

Baxter Healthcare is voluntarily recalling nine lots of Heparin because of the reports of serious adverse reactions to the injections.

Reported adverse events include abdominal pain, decreased blood pressure, burning sensation, chest pain, diarrhea, dizziness, drug ineffectiveness, dyspepsia, dyspnea, erythema, flushing, headache, hyperhidrosis, hypoesthesia, hypotension, increased lacrimation, loss of consciousness, malaise, nausea, pallor, palpitations, paresthesia, pharyngeal edema, restlessness, vomiting/retching, stomach discomfort, tachycardia, thirst, trismus, and unresponsiveness to stimuli. There have been no reports involving fatality

Baxter has not yet learned the cause of the reactions but is asking all healthcare propfessionals to discontinue using the affected lots immediately. A complete list is of the lots is available in the recall notice.

Societe Generale: Did It Alone Create Monday Panic? - Trader Talk with Bob Pisani - CNBC.com

Societe Generale: Did It Alone Create Monday Panic?

Posted By:Bob Pisani

Societe Generale reported a $7.1 billion trading loss due to a rogue trader making bets on stock index futures. While they were making an announcement, they also took writedowns of about $3 billion for losses in the U.S. real estate market and bond insurers.

There were rumors yesterday, that SocGen might have writedowns, but the trading loss from the rogue trader has got people wondering if a good part of the losses in Europe on Monday may have been due to SocGen dumping losing positions. In other words, a panic on Monday may have its genesis because a major bank was forced to dump positions on one of the thinnest trading days of the year--the severity of which left traders groping for all sorts of explanations.

Short covering: I have said that the last two days were dominated predominantly by short covering in financials and retailers, which are the most heavily shorted sectors. What we needed was more REAL buying, i.e. people who are buying not just because they are covering their short positions. Fortunately, we did get evidence of that in the last hour yesterday.

Larry Sinclair Gay Allegations W/ Barack Obama

Looks like our C.F.R pig barack obama is a bone smuggler. Larry Sinclair admits he performed oral sex on barack obama in a limousine. Looks like we will have the prophetess clinton in the lead for the dems now. :-(

Preview of Interview with Stephen Lewis

stephen lewis from the emc2 aim program. stephen talks about energetic balancing and how it heals "incurable diseases", life force diminishing due to poison in our skies, food and water. i have been on this program for 5-6 months. -st0ckman

Kucinich Enters Articles of Impeachment against Bush jan 28

are we finally going to get this satanist / nazi?

Rogue trader's fraud led to $7.1 billion loss: Societe Generale - MarketWatch

The size of the SocGen fraud dwarfs that of infamous rogue trader Nick Leeson, who racked up losses of around $1.4 billion at Barings Bank in 1995.

Leeson's actions led to the collapse of Barings. Convicted of fraud, he was sentenced to a jail term of six and a half years.

The SocGen trader used his experience of working in the bank's middle- and back-office to hide the huge positions he created, Bouton told investors and the media during a heated press conference.

Pre Market NYSE Arca Morning Update

NYSE Arca Morning Update for Thursday, Jan 24, 2008 :

Stocks trading on NYSE Arca at a price more than 15% away from the previous trade day's consolidated close price. (As of 08:30:00 ET)

Stock	Wednesday's Close	Current Price	Pct Chng	Current NYSE Arca Vol
FFIV	$20.13	$23.94	19%	3,801
FTK	$25.50	$20.68	( 19%)	1,700
SPWR	$74.19	$62.35	( 16%)	224,323

10 Most Active stocks on NYSE Arca as of 08:30:00 ET

Based on Dollar Volume:

Based on Share Volume:

Stock	Dollar Volume
SPY	$210,264,516
QQQQ	$59,278,860
NOK	$34,913,821
IWM	$24,895,394
AAPL	$17,188,242
SPWR	$14,571,331
GOOG	$13,073,114
DIA	$10,385,224
RIO	$7,476,886
TOT	$7,032,012

Stock	Share Volume
SPY	1,567,094
QQQQ	1,334,247
NOK	1,017,731
IWM	359,500
RIO	278,116
SPWR	224,323
NLY	164,400
EBAY	138,975
C	133,082
AAPL	122,339

SocGen's rogue trader earns less than 100,000 euros | Deals | Mergers & Acquisitions | Reuters

Societe Generale's rogue trader earns less than 100,000 euros |

Societe Generale's rogue trader earns less than 100,000 euros

PARIS (Reuters) - The trader behind an alleged 4.9 billion euro fraud at Societe Generale is a man in his thirties earning less than 100,000 euros ($146,500) a year, the French bank said on Thursday.

Societe Generale has declined to name the trader for legal reasons.

"He's in his thirties and has been working for Societe Generale since 2002," Chairman Daniel Bouton told reporters at a news conference.

"His salary was slightly below 100,000 euros a year," said Bouton who earlier said he and his deputy Philippe Citerne would give up their own salaries until June.

Bouton gave no further details on the trader and said he did not know where the man was. He said the bank was starting legal action against him.

Asked whether the trader had sought personal gain from his fraud, Jean-Pierre Mustier, head of Societe Generale's investment banking arm, said: "I don't think so."

Then asked whether the trader was acting alone, Mustier said: "I am convinced he was acting alone."

cnn video coverage: